Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer

European Journal of Surgical Oncology

Volumn 32, Issue 2, 2006, Pages 148-152

  Rietman, J S ^a,b,c   Geertzen, J H B ^b,c   Hoekstra, H J ^b   Baas, P ^a   Dolsma, W V ^b   de Vries, J ^b   Groothoff, J W ^c   Eisma, W H ^b,c   Dijkstra, P U ^b,c  

^a MARTINI HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Breast cancer; Morbidity; Quality of life; Radiation; Sentinel lymph node

Indexed keywords

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CONTROLLED STUDY; DAILY LIFE ACTIVITY; FUNCTIONAL ASSESSMENT; GRIP STRENGTH; HUMAN; INSOMNIA; LINEAR REGRESSION ANALYSIS; LONG TERM CARE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MORBIDITY; MUSCLE STRENGTH; PARESTHESIA; PHYSICAL DISABILITY; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; SENTINEL LYMPH NODE BIOPSY; SHOULDER; SHOULDER PAIN; SYMPTOM; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HAND STRENGTH; HUMANS; LONG-TERM CARE; LYMPH NODE EXCISION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NETHERLANDS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RANGE OF MOTION, ARTICULAR; SENTINEL LYMPH NODE BIOPSY; UPPER EXTREMITY;

EID: 32944467875     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2005.11.008     Document Type: Article

References (42)

1. A. Jemal R.C. Tiwari T. Murray A. Ghafoor A. Samuels E. Ward et al. Cancer statistics, 2004 CA Cancer J Clin 54 1 2004 8-29
2. F. Levi F. Lucchini E. Negri C. La Vecchia The decline in cancer mortality in the European Union, 1988-1996 Eur J Cancer 36 2000 1965-1968
3. W.L. Donegan Prognostic factors: Stage and receptor status in breast cancer Cancer 70 1992 1755-1764
4. C.L. Carter C. Allen D.E. Henson Relation of tumour size, lymph node status, and survival in 24,740 breast cancer cases Cancer 63 1989 181-187
5. M. Schaapveld R. Otter E.G. de Vries V. Fidler J.A. Grond W.T. van der Graaf et al. Variability in axillary lymph node dissection for breast cancer J Surg Oncol 87 1 2004 4-12
6. J.S. Rietman P.U. Dijkstra H.J. Hoekstra W.H. Eisma B.G. Szabo J.W. Groothoff et al. Late morbidity after treatment of breast cancer in relation to daily activities and quality of life; a systematic review Eur J Surg Oncol 29 3 2003 229-238
7. K. Poole L.J. Fallowfield The psychological impact of post-operative arm morbidity following axillary surgery for breast cancer: A critical review The Breast 11 2002 81-87
8. J.S. Rietman P.U. Dijkstra R. Debreczeni J.H.B. Geertzen D.P.H. Robinson J. Vries de Impairments, disabilities and health related quality of life after treatment for breast cancer: A follow-up study 2.7 years after surgery Disabil Rehabil 26 2 2004 78-84
9. A.E. Giuliano P.S. Dale R.R. Turner D.L. Morton S.W. Evans D.L. Krasne et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy Ann Surg 222 3 1995 394-399
10. U. Veronesi G. Paganelli V. Galimberti G. Viale S. Zurrida M. Bedoni et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymphnodes Lancet 349 9069 1997 1864-1867
11. A.M. Naik J. Fey M. Gemignani A. Heerdt L. Montgomery J. Petrek et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: A follow-up study of 4008 procedures Ann Surg 240 3 2004 462-471
12. P. Schrenk R. Rieger A. Shamiyeh W. Wayand Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma Cancer 88 2000 608-614
13. A. Haid R. Köberle-Wührer M. Knauer J. Burtscher H. Fritzsche W. Peschina et al. Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: A comparative evaluation Br Cancer Res Treat 73 2002 31-36
14. W.E. Burak S.T. Hollenbeck E.E. Zervos K.L. Hock L.C. Kemp D.C. Young Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer Am J Surg 183 1 2002 23-27
15. L.K.F. Temple R. Baron H.S. Cody J.V. Fey H.T. Thaler P.I. Borgen et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: A prospective study of 233 women Ann Surg Oncol 9 7 2002 654-662
16. K.K. Swenson M.J. Nissen C. Ceronsky L. Swenson M.W. Lee T.M. Tuttle Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer Ann Surg Oncol 9 8 2002 745-753
17. A. Haid P. Kuehn R. Konstantiniuk R. Köberle-Wührer M. Knauer R. Kreienberg et al. Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer Eur J Surg Oncol 28 2002 705-710
18. M. Leidenius E. Leppänen L. Krogerus K. von Smitten Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer Am J Surg 185 2003 127-130
19. M.P. Schijven A.J.J.M. Vingerhoets H.J.T. Rutten G.A.P. Nieuwenhuijzen R.M.H. Roumen M.E. van Bussel et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy Eur J Surg Oncol 29 2003 341-350
20. J.M.M.A. Ververs R.M.H. Roumen A.J.J.M. Vingerhoets G. Vreugdenhil J.W.W. Coebergh M.A. Crommelin et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer Eur J Cancer 37 2001 991-999
21. F. Peintinger R. Reitsamer H. Stranzl G. Ralph Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients Br J Cancer 89 2003 648-652
22. J. Engel J. Kerr A. Schlesinger-Raab H. Sauer D. Hölzel Axilla surgery severely affects quality of life: Results of a 5-year prospective study in breast cancer patients Br Cancer Res Treat 79 2003 47-57
23. International Union Against Cancer Breast tumors L.H. Sobin Ch. Wittekind TNM classification of malignant tumors 6th ed 2002 Wiley-Liss New York 131-142
24. E.J. Rutgers L. Jansen O.E. Nieweg J. de Vries H. Schraffordt Koops B.B. Kroon Technique of sentinel node biopsy in breast cancer Eur J Surg Oncol 24 4 1998 316-319
25. L. Gerber M. Lampert C. Wood M. Duncan T. D'Angelo W. Schain et al. Comparison of pain, motion and edema after modified radical mastectomy vs. local excision with axillary dissection and radiation Br Cancer Res Treat 21 2 1992 139-145
26. S. Green R. Buchbinder A. Forbes N. Bellamy A standardised protocol for measurement of range of movement of the shoulder using the Plurimeter-V inclinometer and assessment of its intrarater and interrater reliability Arthritis Care Res 11 1 1998 43-52
27. van der Ploeg RJO. Hand-held dynamometry. Thesis. The Netherlands: University of Groningen; 1992.
28. R.J.O. van der Ploeg V. Fidler H.J.G.H. Oosterhuis Hand-held myometry: reference values J Neurol Neurosurg Psych 54 1991 244-247
29. V. Mathiowetz K. Weber G. Volland N. Kashman Reliability and validity of grip and pinch strength evaluations J Hand Surg 9 2 1984 222-226
30. J. Sitzia Volume measurement in lymphoedema treatment: Examination of formulae Eur J Cancer Care 4 1 1995 11-16
31. R.S. Meijer J.S. Rietman J.H.B. Geertzen C. Bosmans P.U. Dijkstra Validity and intra and interobserver reliability of an indirect volume determination of patients with edema of the upper extremity Lymphology 37 3 2004 127-134
32. G.J. van der Heijden P. Leffers L.M. Bouter Shoulder disability questionnaire design and responsiveness of a functional status measure J Clin Epidemiol 53 1 2000 29-38
33. G.I. Kempen I. Miedema J. Ormel W. Molenaar The assessment of disability with the Groningen activity restriction scale. Conceptual framework and psychometric properties Soc Sci Med 43 1996 1601-1610
34. Th.P.B.M. Suurmeijer D.M. Doeglas T. Moum et al. The Groningen activity restriction scale for measuring disability: Its utility in international comparisons Am J Public Health 84 8 1994 170-173
35. N.K. Aaronson S. Ahmedzai B. Bergman M. Bullinger A. Cull N.J. Duez et al. The European organisation for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 5 1993 365-376
36. P. Fayers N.K. Aaronson K. Bjordal M. Sullivan EORTC QLQ-C30 scoring manual 1997 EORTC Publications Brussels
37. J.S. Rietman P.U. Dijkstra J.H.B. Geertzen P. Baas J. de Vries W. Dolsma et al. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer Cancer 98 2003 690-696
38. J.S. Rietman P.U. Dijkstra J.H.B. Geertzen P. Baas J. de Vries W.V. Dolsma et al. Treatment-related upper-limb morbidity one year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer Ann Surg Oncol 11 2004 1018-1024
39. M.T. King The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30 Qual Life Res 5 1996 555-567
40. E.M. Sugden M. Rezvani J.M. Harrison L.K. Hughes Shoulder movement after the treatment of early stage breast cancer Clin Oncol 10 1998 173-181
41. S.M. Bentzen M. Overgaard H.D. Thames Fractionating sensitivity of a functional endpoint: Impaired shoulder movement after post-mastectomy radiotherapy Int J Radiat Oncol Biol Phys 17 1989 531-537
42. J. Engel J. Kerr A. Schlesinger-Raab H. Sauer D. Hölzel Quality of life following breast-conserving therapy or mastectomy: Results of a 5-year prospective study Breast J 10 3 2004 223-231